Monica Weldon

President/Chief Executive Officer/FounderPresident/Chief Executive Officer/Founder

Back to Speakers

In November of 2012, Monica’s twin son, Beckett, was the first to be diagnosed at Texas Children’s Genetics Clinic with the gene mutation SYNGAP1. When Beckett was 4 months old, we noticed he was not meeting the same milestones as his twin sister. We then began a journey to find answers to help our son. She began to blog about his progress & this led to building a community of parents & caregivers & a strong support group. She is the Founder, President/CEO SYNGAP1 Foundation. SYNGAP1 is the top single gene mutation linked to Autism in the world and linked to many other neurological conditions, such as Intellectual Disability, Epilepsy and Schizophrenia.
She retired in 2016 after 23 years in education teaching secondary science. Her new focus is on building the programs & mission of the Foundation. She is the Primary Investigator on the SYNGAP1 (MRD5) Registry & Natural History Study, the largest in the world. She is a life member of the Worldwide Association of Female Professionals, DIA 2016 Patient Scholar, a member of the first-class of 2017 Illumina Ambassadors established in the United States and a member of Women in Bio – Capital DC and Texas Chapters.
In addition to leading the foundation, she is an author, public speaker, consultant on rare disease business strategies & advocates for rare disease legislation at both the federal & state levels. Several of her authored scientific publications include Nature Neuroscience, The Journal of Neurodevelopmental Disorders, The Journal of Pediatrics and Value in Health Journal. She has authored a book about her son She currently is a Northwestern University Pritzker Law School candidate earning her master of science law with a concentration in Health Law and graduating Fall 2022.